BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Knesset sets special panel to fast-track Karhi’s communications reform - 2A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- 3A definitive Manual for Internet Mastering and Expertise Improvement
- 4CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- 5Winter storm headed for Midwest to Northeast. Here's how much snow to expect.
- 4 well known subjects in school
- Reclassifying Achievement: Individual Accounts of Seeking after Interests
- Going on a bad date is a drag. Worse? Ending up as a cautionary tale on TikTok.
- From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- Exploring the Difficulties of Beginning a Family: Individual Experiences
- Finding the Universe of Computer generated Reality: Individual Encounters
- What's an atmospheric river? AP explains the weather phenomenon
- Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Mom finds out she has cancer after noticing something was off while breastfeeding
